Taro Pharmaceutical Industries financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Rev. Revenue
$0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $430.91M $543.08M $670.95M $759.29M $862.94M $950.75M $879.39M $661.91M $669.89M $644.77M $548.97M $561.35M $572.95M $0.00M $0.00M
GM % Gross Margin %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 58.58% 67.32% 73.75% 76.39% 78.40% 82.15% 76.36% 70.03% 66.54% 62.00% 54.04% 52.22% 46.83% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 31.00% 43.75% 53.94% 57.01% 60.66% 64.95% 58.59% 46.06% 43.67% 38.24% 26.44% 22.25% 3.09% 0.00% 0.00%
EPS Earnings Per Share
$0.19 $-2.82 $0.60 $1.27 $1.09 $6.57 $8.19 $11.24 $12.69 $11.26 $6.22 $7.15 $6.35 $2.77 $0.68 $1.10 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0 0 0 0 0 0 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0 0 0 0
Sha. Shares
28.97m 29.53m 29.53m 29.62m 36.45m 39.46m 39.25m 44.54m 44.48m 42.83m 42.83m 42.83m 41.03m 40.1m 39.02m 38.26m 38.26m 37.58m 37.58m 37.58m 0m
OCF Operating Cash Flow
$0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $97.43M $235.14M $248.65M $357.64M $406.79M $395.13M $437.54M $323.69M $323.71M $271.61M $45.77M $-158.70M $31.75M $0.00M $0.00M
FCF Free Cash Flow
$0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $93.88M $228.12M $239.18M $336.40M $386.79M $376.16M $401.78M $296.80M $296.69M $244.98M $28.78M $-170.50M $14.17M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.12 $5.13 $5.34 $7.49 $9.03 $8.78 $9.73 $7.33 $7.52 $6.32 $0.75 $-4.54 $0.37 $0.00 $0.00